Filter by tags: Australia Medicine Clear all tag filters
4 news articles found
The Australian government has officially outlined plans for a new nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, replacing an existing facility that is now reaching the end of its operating life. The new facility is expected to be completed by the early to mid-2030s.
- Source: World Nuclear News
- Date: Friday, 06 October 2023
- Original article: world-nuclear-news.org/Articles/Australian-government-funding-to-futureproof-radio
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
The Australian Nuclear Science and Technology Organisation (ANSTO) and Canada’s Terrestrial Energy have agreed to explore ANSTO Synroc (synthetic rock) proprietary waste treatment technology for used fuel management.
- Source: NEI Magazine
- Date: Friday, 04 February 2022
- Original article: neimagazine.com/news/newsterrestrial-energy-and-ansto-sign-agreement-for-used-fuel-management-9459924
The Australian Nuclear Science and Technology Organisation (ANSTO) said on 7 April that Monash University researchers had identified the structure of a protein in the COVID-19 virus, which could be used in screening potential therapeutic drugs.
- Source: NEI Magazine
- Date: Friday, 10 April 2020
- Original article: neimagazine.com/news/newsscientists-identify-covid-19-protein-using-australian-synchrotron-7866759